Introduction: Many oral surgeons, in clinical practice, face the challenge of management
INTRODUCTION
Epidemiological studies show that more than 72% of the American population over the age of 60 years has some type of cardiovascular disease (CVD), and almost 80 million adults have one or more types of CVD. The mortalities resulting from this group of diseases are higher than those resulting from cancer or chronic respiratory diseases 1 . Some indications for the use of oral anticoagulants are CVDs such as atrial fibrillation, previous myocardial infarction, congestive heart failure, and valvular heart lesions 2 . The most commonly used category of oral anticoagulants is vitamin K antagonists, since vitamin K participates in the carboxylation of several blood coagulation proteins, mainly prothrombin and factor VII 3 .
Performing dental procedures in patients on anticoagulant therapy is a point of controversy; performing a dental procedure while continuing the therapy carries the risk of hemorrhage during and after the surgical procedure, in contrast to the suspension of the drug that could lead to a thromboembolic event. A meta-analysis compared the bleeding risk in patients continuing oral anticoagulant therapy with that in patients who had discontinued it. Although the risk ratio was slightly higher in those who continued to use the drug, this was not statistically significant, and therefore, the authors consider that there is no increase in the risk of bleeding 4 . Thus, the recommended dental practice is based on monitoring of the coagulation levels through serological investigations and performing surgical procedures with preventive measures. The aim of this study was delineate the oral anticoagulate patients' profile in terms of the systemic and technical conditions related to the dental extraction.
METHODS

This research was performed in Porto Alegre
Clinical Hospital (HCPA) with the approval of the ethical committee (number 1.571.215 HCPA/UFRGS) in accordance with the Helsinki Declaration. The review was conducted using clinical electronic records of all the patients who underwent dental procedures with special attention to the patients on oral anticoagulant therapy between January 2014 and December 2015. 
Variables
The clinical data recorded about the patients included age, gender, systemic disease, prothrombin time, and INR before the dental intervention; regarding oral anticoagulant medication in use, the type and weekly dose were recorded; regarding the local procedure, the number of teeth extracted in each consultation, use of antibiotic prophylaxis, and presence of trans-and postoperatory bleeding complications were recorded.
Procedure
Dental extraction was performed after monitoring PT and INR at least 7 days before the surgery. The procedure was performed under local anesthesia (Citanest 3% ® , Prilocaine Hydrochloride 30 mg, Felipressin 0.03 IU, Dentisply, Petrópolis/RJ -Brazil), without the use of additional techniques such as mucoperiosteal flap, osteotomy, or odontosection. Collagen sponges (Hemospon ® , Technew, Rio de Janeiro/RJ -Brazil) were placed routinely in the bone defect, and primary closure of the wound was attempted with compressive sutures and dry gauze pressure over the wound for at least 30 minutes post-surgically.
RESULTS
A total of 60 patients with 82 surgical procedures and 145 extracted teeth were reviewed, the sample profile is show in the Table 1 . The number of dental extractions according to tooth type is show in the Figure 1 . The mean number of teeth extracted per consultation was 1.76 (± 1.17 SD) (minimum 1 to maximum 6), (Figure 2 ). All patients were taking warfarin for anticoagulation. Additionally, the correlation between the study variables is show in Table 2 . 
DISCUSSION
The purpose of this study was to analyze the complications such as bleeding or infection after dental extraction in patients on oral anticoagulant therapy; trans-and post-surgical intercurrences were not observed in this sample. A profile of this group was delineated to assist the dentists in performing dental procedures safely, as well as to draw the characteristics of the techniques.
The number of men in our study was slightly higher than that of women; CVD affects as many men as women, as the risk factors are very similar for both groups (i.e., tobacco, physical inactivity, alcohol abuse, hypertension, cholesterol, and diabetes) 5 . In our study, the mean age was 59 years; with aging, vascular alterations like arterial thickening can cause endothelial dysfunction, thereby increasing the systolic pressure which predisposes one to CVD 6 . The most prevalent pathologies found in this research were cardiac valve disease (corrected using prostheses), congestive heart failure, cerebral vascular accident, and atrial fibrillation; the distribution of global CVD burden is principally due to ischemic heart and cerebrovascular diseases 7 . The use of anticoagulants for prevention of blood clot formation is very common. One of the most commonly used oral anticoagulants is warfarin (Marevan ® , Coumadin ® , Jantoven ® ) 8 . The suspension of this drug to perform dental procedures has been controversial; current research shows that the risk of complications such as fatal embolism, fatal massive cerebral thrombosis, transient ischemic attack, fatal myocardial infarction, and cardioembolic strokes by the suspension of anticoagulants is much higher than the possible oral bleeds that can be treated with local hemostatic measures if anticoagulant therapy is continued during dental surgery 9 . An important method for monitoring the anticoagulation is by the means of INR and PT; these serological investigations are used as guides for the management of surgical oral procedures without interrupting oral anticoagulant therapy; in a multicentric study, data from 2817 dental extraction were analyzed using multivariable analysis to evaluate several conditions. The main risk factor for post extraction bleeding was found to be PT-INR (odds ratio [OR] 7.797) 10 .
The European Society of Cardiology recommends other methods to evaluate the bleeding risk in patients under oral anticoagulant therapy e.g., the HAS-BLED score. This test analyzes nine risk factors such as age, history of stroke or previous bleeding, systolic blood pressure, renal or liver dysfunction, use of antiplatelet agents or non-steroidal anti-inflammatory drugs 11 . In a retrospective cohort study, Kataoka et al. 12 evaluated the HAS-BLED score for its use in patients taking warfarin, and concluded that the when measured alone, the score could not predict post-extraction bleeding.
In our practice, we utilized the PT-INR investigations before performing dental surgical procedures. The mean INR was 2.47 and the procedures performed in patients with INR less than 4.0 were without intercurrences. There is a controversy about the safe INR for performing surgical procedures; some surgeons consider values up to 3.0 safe 10,13 while others 14, 15 following the British Health Committees guidelines of small surgical procedures like dental extraction (single or multiple) consider performing dental surgical procedures safe in patients with therapeutic INR in the range of 2 to 4, provided local hemostatic agents are used, such as oxidized cellulose (Surgicel ® ) and 5% tranexamic acid mouthwash four times a day for two days, in addition to avoiding the prescription of nonselective non-steroidal anti-inflammatory drugs, especially COX-2 inhibitors 16 . The correlation between the weekly dose of warfarin and INR or PT was not established; this may be due to other compounds that may have altered the anticoagulation. Drugs, herbal products, and foods can result in pharmacokinetic interactions and may influence the warfarin effect, for example, cimetidine, omeprazole, fish oil, mango, boldo-fenugreek tea potentiate the effect of warfarin, whereas barbiturates, high vitamin K content foods/enteral feeds, avocado, and ginseng have an inhibitory effect on warfarin 17 . Novel oral anticoagulants such as direct thrombin inhibitors (dabigatran) and factor Xa inhibitors (rivaroxaban) pose a new challenge for the dentists because of their increased use by the patients and lack of clinical guidelines for their management 18 . Some recommendations are planning with the physician in procedures where excessive bleeding is anticipated and/ or in cases with impaired hemostasis. The use should be discontinued at least 24 hours before the elective surgery and local hemostatic conducts are advised 19 . Additional studies such as clinical trials are necessary for establishing the safe management of such patients.
CONCLUSION
Performing minor oral surgeries in patients on oral anticoagulant therapy can be safe. In this observed sample, no trans-and post-surgical intercurrences were observed. Based on this research, we suggest performing dental surgical procedures in patients on oral anticoagulant therapy only when INR is less than 4, with good surgical planning including antibiotic cover, extraction of one tooth at a consultation without atraumatic techniques, use of hemostatic agents, and primary closure of the wound. These practices must be followed strictly, so that there are no complications in these procedures in this special group of patients on anticoagulant therapy.
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